Category: SeaPRwire

Seoul, Korea – July 10, 2024 – (SeaPRwire) – Vine Strategy is excited to announce the launch of its improved web-based client portal, designed to provide a more seamless, intuitive, and secure experience for clients. This upgrade is part of Vine Strategy’s ongoing commitment to leveraging technology to enhance client engagement and service delivery. Enhanced usability The newly launched portal offers a range of enhanced features designed to provide clients with better access to their investment information and more powerful tools for managing their portfolios. Key features include: A reimagined, intuitive interface that makes navigation easy and user-friendly also offers features superior security measures including 2FA (two factor authentication) and military-grade encryption designed to keep client data safe and secure. Clients benefit from instant access to account balances, transaction history and real-time market data to keep informed about their portfolios. Comprehensive tools The improvements extend to a suite of comprehensive tools that enable users to produce detailed reports on their investment performance and track their financial objectives. Newly-added features include dashboards that can provide clients with a personalized view of their portfolios, including useful key performance indicators and up to date market insights. More ways to communicate The updated portal enables clients to liaise more closely with their personal advisors via direct messaging vectors that further facilitate the efficient delivery of Vine Strategy’s high levels of service “At Vine Strategy, we’re dedicated to providing our clients with the best possible experience,” said Vine Strategy’s co-founding partner, George Chan. “The enhancements to our web-based client portal are designed to offer greater transparency, security and convenience which helps our clients to make better-informed investment decisions.” The launch of the improved portal is part of Vine Strategy’s drive to leverage technology in order to deliver superior client service. By continuously investing in digital innovation, Vine Strategy aims to meet the evolving needs of its clients and set new standards in the investment management industry. “We believe that our clients deserve the highest level of service and access to the best tools available,” Mr. Chan added. “This enhanced portal is a testament to our commitment to excellence and our desire to support our clients in achieving their financial goals.” About Vine Strategy Vine Strategy is a leading financial services firm dedicated to providing strategic financial solutions and investment management expertise. With a strong focus on sustainable investments, Vine Strategy aims to support clients in navigating emerging markets and industries while fostering positive environmental and social impact. Know more please contact +822-180-276-2983 or visit our office at World Trade Center, 511 Young Dong St, Gangnam-gu, Seoul, South Korea. Media contact Brand: Vine Strategy Contact: David Greenfield Website: https://vinestrategy.com SOURCE: Vine Strategy The article is provided by a third-party content provider. SeaPRwire ( https://www.seaprwire.com/ ) makes no warranties or representations in connection therewith. Sectors: Top Story, Corporate News SeaPRwire provides real time press release distribution for companies and organizations to 6,500+ media outlets & 3.5 million professional desktops in 90 regions. It distributes press releases in different languages, including: IndonesiaFolk, IndoNewswire, SEATribune, IDNewsZone, LiveBerita, DailyBerita, TaiwanPR, SinchewBusiness, AsiaEase, BuzzHongKong, SingapuraNow, TIHongKong, TaipeiCool, TWZip, AsiaFeatured, dePresseNow, THNewson, KULPR, VNFeatured, MENAEntry, HunaTimes, DubaiLite, ArabicDir, BeritaDaring, TekanAsia, JamKopi ...

July 09, 2024 - (SeaPRwire) - Asia has consistently been at the forefront of shaping global music trends. From the explosive popularity of K-pop to innovative music streaming platforms, the region is a powerhouse in the music industry. Countries like South Korea, Japan, and China are significant music markets and trendsetters, influencing global music consumption and production patterns. South Korea's Influence with K-pop South Korea, in particular, has profoundly impacted the global music scene through K-pop. This genre has transcended cultural and language barriers, gaining massive international followings. Groups like BTS and Blackpink have become household names, setting records on global music charts and social media platforms. K-pop's unique blend of catchy music, high-quality production, and strong visual elements has redefined how music is marketed and consumed worldwide. Japan's Music and Technology Integration Japan, another key player, continues to blend music with cutting-edge technology. The country is known for its diverse music scene, from J-Pop to classical music, and its pioneering efforts in integrating music with digital technology. Japanese music streaming services and virtual concerts are becoming increasingly popular, setting new standards for how music can be experienced in the digital age. China's Expanding Market China's music industry is also rapidly expanding, with a burgeoning digital music market. Platforms like QQ Music and NetEase Cloud Music dominate the scene, offering vast libraries of music and innovative features that cater to the preferences of Chinese consumers. Integrating social media with music streaming has created a dynamic ecosystem where users can interact and engage with their favorite artists more directly. Music Protocol's Vision for Asia Recognizing Asia's pivotal role in the music industry, Music Protocol is poised to make significant inroads into the region. Focusing on Korea, Music Protocol aims to establish a hub leveraging the country's robust music industry and technological advancements. This strategic move aligns with Music Protocol’s mission to tokenize music catalogues, providing a transparent and efficient way to manage and monetize music rights. Why Korea? Korea's advanced digital infrastructure and its position as a global leader in the music industry make it an ideal location for Music Protocol's hub. The country's openness to technological innovation and its strong intellectual property laws provide a solid foundation for integrating blockchain technology into music rights management. By establishing a presence in Korea, Music Protocol aims to support local artists and rights holders, offering them new opportunities for revenue generation and global reach. Embracing Innovation with Music Protocol Music Protocol’s entry into Asia, particularly South Korea, represents a significant step towards advancing the music industry through blockchain technology. By converting traditional music royalties into digital, liquid Real-World Assets (RWAs), Music Protocol not only enhances transparency and efficiency but also opens up new avenues for investment in the music sector. Asia's influence on the global music industry is undeniable, with countries like South Korea, Japan, and China leading the charge in setting trends and integrating technology. Music Protocol’s focus on establishing a hub in Korea underscores the importance of this region in their strategic plans. As Music Protocol continues to innovate and expand, it aims to transform the music industry by offering a new, blockchain-based approach to managing and monetizing music rights, benefiting artists, rights holders, and investors alike. The $RECORD LBP is now live on Fjord Foundry. This event marks a significant milestone, offering early adopters the chance to be part of a new chapter for the music industry. Voice of Asia: Asia and Music Protocol leading the way for RWAs (to be translated) Asia is rapidly emerging as a global leader in the tokenization of real-world assets (RWAs). The region's embrace of blockchain technology and innovative financial solutions is transforming how assets are managed and traded. According to a recent report by PwC, the global market for RWA tokenization could reach $1.5 trillion by 2025, with Asia playing a pivotal role in this growth. Statistics Highlighting Asia's Role Market Size and Growth: In 2022, Asia accounted for over 40% of the global RWA tokenization market, with significant contributions from countries like China, Japan, and South Korea. Investment and Adoption: The Asian market has seen a surge in investment in blockchain technology, with over $1 billion invested in RWA tokenization projects in the past two years. Government Support: Governments in the region are increasingly supporting blockchain initiatives. For instance, Singapore's government has launched several programs to promote the use of blockchain in finance and real estate. Music as an Alternative Asset Class Within the broader RWA sector, music is emerging as a promising alternative asset class. Traditionally, music rights and royalties have been illiquid and inaccessible to the average investor. However, the tokenization of music rights is changing this landscape by converting these rights into digital tokens that can be easily traded on blockchain platforms. Market Potential: The global music industry is valued at over $50 billion, with a significant portion of this value tied up in royalties and intellectual property. Tokenizing these assets can unlock billions of dollars in value. Investor Interest: There is growing interest from institutional investors in music as an asset class. Music royalties offer a stable and predictable income stream, making them an attractive investment in volatile markets. Music Protocol: Bridging the Gap Music Protocol is at the forefront of this transformation, leveraging blockchain technology to create a transparent and efficient market for music rights. By converting traditional music royalties into liquid digital assets, Music Protocol is democratising access to this lucrative market. How Music Protocol Works Tokenization of Music Rights: Music Protocol enables the tokenization of music royalties, allowing artists and rights holders to monetize their intellectual property more effectively. This process involves converting the future cash flows from music royalties into digital tokens that can be traded on blockchain platforms. Utility of $RECORD Token: The $RECORD token is central to Music Protocol’s ecosystem. It drives adoption, rewards contributors, and governs the network economy. Additionally, $RECORD token holders can participate in the Music Passive Reward (MPR) Framework, which incentivizes artists to register their music IP on the network. Regulatory Compliance: Music Protocol’s $RECORD token is approved by the Swiss Financial Market Supervisory Authority (FINMA) as a utility token, ensuring full compliance with industry regulations. The Future of Music as an Asset Class The tokenization of music rights offers numerous benefits, including increased liquidity, lower entry barriers, and enhanced transparency. As more investors recognize the potential of music as an alternative asset class, platforms like Music Protocol are well-positioned to lead this new market. Asia's leadership in the RWA sector is driving significant innovations and opportunities, particularly in the tokenization of music rights. Music Protocol’s innovative approach to converting music royalties into digital assets is opening new avenues for investment and growth. With its robust platform and regulatory compliance, Music Protocol is set to revolutionise the music industry and establish music as a viable and attractive asset class for investors worldwide. As the RWA sector continues to expand, Music Protocol’s focus on the Asian market, particularly South Korea, underscores the importance of this region in their strategic plans. By leveraging Asia's technological advancements and robust music industry, Music Protocol is poised to become a key player in the global RWA market. The $RECORD LBP is now live on Fjord Foundry. This event marks a significant milestone, offering early adopters the chance to be part of a new chapter for the music industry. The article is provided by a third-party content provider. SeaPRwire ( https://www.seaprwire.com/ ) makes no warranties or representations in connection therewith. Sectors: Top Story, Corporate News SeaPRwire provides real time press release distribution for companies and organizations to 6,500+ media outlets & 3.5 million professional desktops in 90 regions. It distributes press releases in different languages, including: IndonesiaFolk, IndoNewswire, SEATribune, IDNewsZone, LiveBerita, DailyBerita, TaiwanPR, SinchewBusiness, AsiaEase, BuzzHongKong, SingapuraNow, TIHongKong, TaipeiCool, TWZip, AsiaFeatured, dePresseNow, THNewson, KULPR, VNFeatured, MENAEntry, HunaTimes, DubaiLite, ArabicDir, BeritaDaring, TekanAsia, JamKopi ...

Seoul, Korea – July 08, 2024 – (SeaPRwire) – ZEUS Investments, a leading South Korea investment management firm, today released a comprehensive analysis on the shifting landscape of investor sentiment in the Asia Pacific region. This report provides a detailed examination of the emerging trends and factors influencing investor behavior in one of the world’s fastest-growing wealth management markets. Changing economic landscape and investor optimism The report posits that the Asia Pacific region continues to demonstrate robust economic growth, driven by rapid technological advancements, increased consumer spending and burgeoning middle-class demographics. Despite global economic uncertainties, investors remain optimistic about the long-term potential of the region. ZEUS Investments has observed a noticeable shift towards sustainable investments, with a growing preference for companies that demonstrate strong environmental, social, and governance (ESG) practices. The firm says key trends influencing investor sentiment include the ongoing proliferation of digital technologies, including artificial intelligence, fintech and e-commerce into everyday life and, consequently, it sees few, if any, signs of the pace of this development abating. Unsurprisingly, investors are increasingly drawn to opportunities in tech-driven sectors in countries like China, Vietnam, South Korea and Japan, a testament to the region’s leadership in innovation. A heightened awareness of sustainability’s importance There is a heightened awareness among investors about the importance of sustainability. Companies that prioritize ESG criteria are attracting more investment as investors prioritize the alignment of their portfolios with ethical and sustainable practices. Geopolitical events including the conflicts raging in Ukraine and Gaza continue to impact global investor sentiment but the resilience and adaptability of markets in the Asia Pacific region have mitigated many of the negative effects, with the perception among many investors being that, with the exception of occasional North Korean belligerence, Asia appears insulated. ZEUS Investments’ strategic approach In response to these evolving trends, ZEUS Investments has reinforced its commitment to identifying and capitalizing on high-growth opportunities in the Asia Pacific region. The firm relies heavily on a rigorous, research-driven approach, leveraging its deep local market expertise and global investment capabilities to deliver superior returns for its clients. “We are witnessing a transformative period in the Asia Pacific region, characterized by significant growth and innovation,” said George Zhu, CEO of ZEUS Investments. “Our investment strategy is focused on identifying companies that are at the forefront of technological innovation, green energy and sustainable practices, which we believe will continue to drive long-term value for our clients.” The ZEUS Investments report is available upon request. About ZEUS Investments ZEUS Investments is a leading investment management firm dedicated to delivering superior investment results and exceptional client service. With a team of experienced professionals and a disciplined approach to investing, we strive to provide our clients with innovative solutions and opportunities for long-term growth. For media inquiries Brand: ZEUS Investments South Korea Contact: Hyeong Kwang-Sun Website: https://zeusnus.com SOURCE: ZEUS Investments South Korea The article is provided by a third-party content provider. SeaPRwire ( https://www.seaprwire.com/ ) makes no warranties or representations in connection therewith. Sectors: Top Story, Corporate News SeaPRwire provides real time press release distribution for companies and organizations to 6,500+ media outlets & 3.5 million professional desktops in 90 regions. It distributes press releases in different languages, including: IndonesiaFolk, IndoNewswire, SEATribune, IDNewsZone, LiveBerita, DailyBerita, TaiwanPR, SinchewBusiness, AsiaEase, BuzzHongKong, SingapuraNow, TIHongKong, TaipeiCool, TWZip, AsiaFeatured, dePresseNow, THNewson, KULPR, VNFeatured, MENAEntry, HunaTimes, DubaiLite, ArabicDir, BeritaDaring, TekanAsia, JamKopi ...

Seoul, South Korea – July 05, 2024 – (SeaPRwire) – Mormont Financial is pleased to announce the promotion of Mr. Jung Jun-seo from Senior Recruitment Manager to Director of Recruitment. “This is a logical step for our recruitment division. Throughout his years of experience in recruitment, Jun-seo has cultivated a deep understanding of the financial services market, the talent available and the challenges businesses such as ours face when securing, onboarding and ultimately, retaining new staff members,” said Alexander Stevine, Chief Executive Officer at Mormont Financial. “Jun-seo has been a key member of our recruitment team for a number of years, tailoring recruitment solutions that have consistently delivered outstanding candidates to our key roles. We’re delighted to entrust him with the challenging task of growing and sustaining our teams now and into the future.” In his new role, Mr. Jung will oversee all recruitment-related matters at Mormont Financial’s sales & trading office in Seoul as the company looks to the planned expansion of research operations expected to commence in the third quarter of 2024. He is expected to implement an innovative new-hire program, manage onboarding processes, spearhead training initiatives, oversee the employee benefits program and handle administration requirements. “It’s no exaggeration to say that I am delighted with my new role and will remain committed to sustaining an active corporate culture, retaining and nurturing talented individuals as they progress through their careers with Mormont Financial,” said Mr. Jung referencing his promotion. Mormont Financial employs over 160 highly skilled experts with diverse backgrounds and experience in various fields, financial and otherwise. The company makes an unwavering commitment to the well-being of its employees and their families, providing a range of benefits and encouraging continual vocational training to help team members achieve their full potential. Each year, Mormont Financial recruits new staff from diverse backgrounds, including graduates and experienced professionals with expertise in areas such as banking, sales, compliance and economics. About Mormont Financial Mormont Financial is an independent investment and wealth management concern serving high net worth individuals and families located in the Asia Pacific region and beyond. We are committed to helping our clients achieve their financial goals by offering sage investment guidance and bespoke financial planning services. To know more please contact +822 6138 8666 or visit their office at Level 19, Hana Securities Building, 82 Uisadang-daero, Yeongdeungpo-gu, Seoul. For Media contact Brand: Mormont Financial Contact: Preston Wraith Website: https://www.mfaventure.com SOURCE: Mormont Financial The article is provided by a third-party content provider. SeaPRwire ( https://www.seaprwire.com/ ) makes no warranties or representations in connection therewith. Sectors: Top Story, Corporate News SeaPRwire provides real time press release distribution for companies and organizations to 6,500+ media outlets & 3.5 million professional desktops in 90 regions. It distributes press releases in different languages, including: IndonesiaFolk, IndoNewswire, SEATribune, IDNewsZone, LiveBerita, DailyBerita, TaiwanPR, SinchewBusiness, AsiaEase, BuzzHongKong, SingapuraNow, TIHongKong, TaipeiCool, TWZip, AsiaFeatured, dePresseNow, THNewson, KULPR, VNFeatured, MENAEntry, HunaTimes, DubaiLite, ArabicDir, BeritaDaring, TekanAsia, JamKopi ...

SHENZHEN, CHINA – June 25, 2024 – (SeaPRwire) – On June 25, China Medical System Holdings Limited (the “Company”, together with its subsidiaries, the “Group” or “CMS”) announced the completion of dosing for the first subject in the phase III bridging trial of ruxolitinib cream (the “Product”) in atopic dermatitis (“AD”) in China. This is another substantial clinical development milestone for ruxolitinib cream in China, following the approval for Urgent Clinical Import by Hainan Medical Products Administration and approval for marketing in Macau for vitiligo. This trial is a randomized, double-blind, placebo-controlled phase III clinical trial evaluating the efficacy and safety of ruxolitinib cream in the treatment of atopic dermatitis in Chinese patients. The trial aims to provide more medical evidence to support the Product’s marketing application in China. The trial, led by Professor Shi Yuling, Vice President of Shanghai Skin Disease Hospital, will be conducted in 20 sites nationwide aiming to enroll approximately 192 atopic dermatitis patients. AD is a chronic, recurrent and inflammatory dermatologic disease, with the main clinical manifestations of dry skin, chronic eczema-like lesions and obvious itching or pruritus, which may seriously affect the quality of life of patients. It is estimated that there are approximately 26 million[1] AD patients in China, of whom about 23 million[2] are mild to moderate. Topical drugs are the most basic treatment for AD. Traditional topical medications such as topical corticosteroids (TCSs) and topical calcineurin inhibitors (TCIs) have long-term adverse reactions or limited efficacy[3] [4], therefore novel treatments are urgently needed, especially for those mild to moderate AD patients who do not need systemic treatment. About ruxolitinib cream Ruxolitinib cream (Opzelura®), a novel cream formulation of Incyte’s selective JAK1/JAK2 inhibitor ruxolitinib, is approved by the U.S. Food and Drug Administration (FDA) for the topical treatment of nonsegmental vitiligo in patients 12 years of age and older, and is the first and only treatment for repigmentation approved for use in the United States[5]. Opzelura is also approved in the U.S. for the topical short-term and non-continuous chronic treatment of mild to moderate atopic dermatitis (AD) in non-immunocompromised patients 12 years of age and older whose disease is not adequately controlled with topical prescription therapies, or when those therapies are not advisable[6]. Use of Opzelura in combination with therapeutic biologics, other JAK inhibitors, or potent immunosuppressants, such as azathioprine or cyclosporine, is not recommended. In Europe, ruxolitinib cream (Opzelura) is approved for the treatment of non-segmental vitiligo with facial involvement in adults and adolescents from 12 years of age[7]. Ruxolitinib cream is not approved by the National Medical Products Administration of China (NMPA) for any indication in Mainland of China. However, on 12 August 2023, the Product was approved by Hainan Medical Products Administration for Urgent Clinical Import, and officially became available to applicable patients in the Hainan Boao Lecheng International Medical Tourism Pilot Zone (the “Pilot Zone”) on 18 August, for the topical treatment of non-segmental vitiligo in adults and adolescents aged 12 and above with facial involvement. Benefiting from the Early and Pilot Implementation Policy granted by the state to Hainan Free Trade Port and the Pilot Zone, patients with vitiligo in China can apply for the Product in Boao Super Hospital first and receive treatment from the expert team. The Group is cooperating with Boao Super Hospital to conduct the Real World Research (RWS) for the Product, which could support the registration and launching of the Product in Mainland of China. Moreover, the Pharmaceutical Administration Bureau (ISAF) of Macau has approved the new drug application of ruxolitinib cream for the treatment of non-segmental vitiligo with facial involvement in adults and adolescents from 12 years of age on 11 April 2024, and it may bring a novel therapeutic option to patients with relevant indication in the area. Incyte has worldwide rights for the development and commercialization of the Product, marketed in the United States and Europe as Opzelura®. CMS has an exclusive license to develop and commercialize the Product in Mainland China, Hong Kong Special Administrative Region, Macau Special Administrative Region, Taiwan Region and eleven Southeast Asian countries (the “Territory”) and a non-exclusive license to manufacture the Product in the Territory. Opzelura and the Opzelura logo are registered trademarks of Incyte. CMS continues to pay close attention to patients’ needs, and actively promotes the R&D and clinical application of innovative products to address unmet clinical needs, bringing more quality medical products to patients through differentiated innovation breakthroughs. About CMS CMS is a platform company linking pharmaceutical innovation and commercialization with strong product lifecycle management capability, dedicated to providing competitive products and services to meet unmet medical needs. CMS focuses on the global first-in-class (FIC) and best-in-class (BIC) innovative products, and efficiently promotes the clinical research, development and commercialization of innovative products, enabling the continuous transformation of scientific research into clinical practices to benefit patients. CMS deeply engages in several specialty therapeutic fields, and has developed proven commercialization capabilities, extensive networks and expert resources, resulting in leading academic and market positions for its major marketed products. CMS continues to promote the in-depth development of its advantageous specialty fields and expand business boundaries. While strengthening the competitiveness of the cardio-cerebrovascular/gastroenterology business, CMS independently operates its dermatology and medical aesthetics business, and ophthalmology business, aiming to gain leading positions in specialty therapeutic fields, whilst enhancing the scale and efficiency. At the same time, CMS has expanded its business territory to the Southeast Asian market, striving to become a “bridgehead” for global pharmaceutical companies to enter the Southeast Asian market, further escorting the sustainable and healthy development of the Group. Reference: 1. M.R. Laughter, M.B.C. Maymone, S. Mashayekhi, B.W.M. Arents, C. Karimkhani, S.M. Langan, R.P. Dellavalle, C. Flohr, The global burden of atopic dermatitis: lessons from the Global Burden of Disease Study 1990–2017, British Journal of Dermatology, Volume 184, Issue 2, 1 February 2021, Pages 304–309, https://doi.org/10.1111/bjd.19580 2. Chiesa Fuxench ZC, Block JK, Boguniewicz M, Boyle J, Fonacier L, Gelfand JM, Grayson MH, Margolis DJ, Mitchell L, Silverberg JI, Schwartz L, Simpson EL, Ong PY. Atopic Dermatitis in America Study: A Cross-Sectional Study Examining the Prevalence and Disease Burden of Atopic Dermatitis in the US Adult Population. J Invest Dermatol. 2019 Mar;139(3):583-590. doi: 10.1016/j.jid.2018.08.028. Epub 2018 Oct 30. PMID: 30389491 3. “Research Report on the Living Conditions of Atopic Dermatitis Patients in China” August 2020 4. Yimi Survey “Atopic Dermatitis Diagnosis and Cognition Survey” October 2023 5. Drug approval information can be found on the FDA official website, as follows: https://www.fda.gov/drugs/news-events-human-drugs/fda-approves-topical-treatment-addressing-repigmentation-vitiligo-patients-aged-12-and-older 6. Drug approval information can be found on the Incyte official website, as follows: https://investor.incyte.com/news-releases/news-release-details/incyte-announces-us-fda-approval-opzeluratm-ruxolitinib-cream 7. Drug approval information can be found on the EMA official website, as follows: https://www.ema.europa.eu/en/medicines/human/EPAR/opzelura CMS Disclaimer and Forward-Looking Statements This press release is not intended to promote any products to you and is not for advertising purposes. This press release does not recommend any drugs, medical devices and/or indications. If you want to know more about the diagnosis and treatment of specific diseases, please follow the opinions or guidance of your doctor or other medical and health professionals. Any treatment-related decisions made by healthcare professionals should be based on the patient’s specific circumstances and in accordance with the drug package insert. This press release which has been prepared by CMS does not constitute any offer or invitation to purchase or subscribe for any securities, and shall not form the basis for or be relied on in connection with any contract or binding commitment whatsoever. This press release has been prepared by CMS based on information and data which it considers reliable, but CMS makes no representation or warranty, express or implied, whatsoever, and no reliance shall be placed on, the truth, accuracy, completeness, fairness and reasonableness of the contents of this press release. Certain matters discussed in this press release may contain statements regarding the Group’s market opportunity and business prospects that are individually and collectively forward-looking statements. Such forward-looking statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties and assumptions that are difficult to predict. Any forward-looking statements and projections made by third parties included in this press release are not adopted by the Group and the Company is not responsible for such third-party statements and projections. Media Contact Brand: China Medical System Holdings Ltd. Contact: CMS Investor Relations Email: ir@cms.net.cn Website: https://web.cms.net.cn/en/home/ Source: China Medical System Holdings Ltd.